CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-2094
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
CX3CL1 reduces neurotoxicity and microglial activation in a rat model of Parkinson's disease ; volume:8 ; number:1 ; day:25 ; month:1 ; year:2011 ; pages:1-7 ; date:12.2011
Journal of neuroinflammation ; 8, Heft 1 (25.1.2011), 1-7, 12.2011
- Urheber
-
Pabon, Mibel M.
- Beteiligte Personen und Organisationen
-
Bachstetter, Adam D.
Hudson, Charles E.
Gemma, Carmelina
Bickford, Paula C.
SpringerLink (Online service)
- DOI
-
10.1186/1742-2094-8-9
- URN
-
urn:nbn:de:1111-2016032329899
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Pabon, Mibel M.
- Bachstetter, Adam D.
- Hudson, Charles E.
- Gemma, Carmelina
- Bickford, Paula C.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
Radix Scrophulariae extracts (harpagoside) suppresses hypoxia-induced microglial activation and neurotoxicity
Microglial activation in Parkinson’s disease using [18F]-FEPPA
The brain's best friend: microglial neurotoxicity revisited
Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats
Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity
Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein
Apomorphine Reduces A53T α-Synuclein-Induced Microglial Reactivity Through Activation of NRF2 Signalling Pathway
Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
Radix Scrophulariae extracts (harpagoside) suppresses hypoxia-induced microglial activation and neurotoxicity
Microglial activation in Parkinson’s disease using [18F]-FEPPA
The brain's best friend: microglial neurotoxicity revisited
Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats
Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity
Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein
Apomorphine Reduces A53T α-Synuclein-Induced Microglial Reactivity Through Activation of NRF2 Signalling Pathway
Lenalidomide reduces microglial activation and behavioral deficits in a transgenic model of Parkinson’s disease
Radix Scrophulariae extracts (harpagoside) suppresses hypoxia-induced microglial activation and neurotoxicity
Microglial activation in Parkinson’s disease using [18F]-FEPPA
The brain's best friend: microglial neurotoxicity revisited
Microglial MAC1 receptor and PI3K are essential in mediating β-amyloid peptide-induced microglial activation and subsequent neurotoxicity
Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
Gabapentin reduces CX3CL1 signaling and blocks spinal microglial activation in monoarthritic rats
Microglial activation contributes to cognitive impairments in rotenone-induced mouse Parkinson’s disease model
Microglial Activation and Antioxidant Responses Induced by the Parkinson’s Disease Protein α-Synuclein
α-Mangostin Inhibits α-Synuclein-Induced Microglial Neuroinflammation and Neurotoxicity
Prostaglandin E2 receptor subtype 2 (EP2) regulates microglial activation and associated neurotoxicity induced by aggregated α-synuclein